News

• Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
  03/24/2022 / 07:00 - GlobeNewswire
•  
• Addex Reports Full Year 2021 Financial Results and Provides Corporate Update
  03/10/2022 / 07:10 - GlobeNewswire
•  
• Addex Therapeutics to Release Full-Year 2021 Financial Results and Host Conference Call on March 10, 2022
  03/07/2022 / 07:00 - GlobeNewswire
•  
• Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO Forums
  02/24/2022 / 07:00 - GlobeNewswire
•  
• Addex Increases Issued Share Capital to Create Treasury Shares
  02/03/2022 / 07:00 - GlobeNewswire
•  
• Addex to Present at the Swiss Equities Baader Virtual Conference
  01/11/2022 / 07:00 - GlobeNewswire
•  
• Addex to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
  01/06/2022 / 07:00 - GlobeNewswire
•  
• Addex Raises $10.0 Million in Equity Financing
  12/17/2021 / 07:00 - GlobeNewswire
•  
• Addex Provides Year End Pipeline Development Update
  12/15/2021 / 07:00 - GlobeNewswire
•  
• Addex to Present at the Virtual German Equity Forum
  11/18/2021 / 07:00 - GlobeNewswire
•  
• Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
  11/15/2021 / 07:00 - GlobeNewswire
•  
• Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
  11/15/2021 / 07:00 - GlobeNewswire
•  
• Addex Reports Q3 2021 Financial Results and Provides Corporate Update
  11/04/2021 / 07:00 - GlobeNewswire
•  
• Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021
  11/01/2021 / 07:00 - GlobeNewswire
•  
• Addex to Present at the Investors’ Day hosted by Voxia Communication
  10/06/2021 / 07:00 - GlobeNewswire